SavedAdd your journal

Journals / Turkish Journal of Hematology / 2002 / Cilt: 19 - Sayı: 2

The prevalence of activated protein C resistance and F V leiden in healthy population of Edirne, Turkey

Mutlu VURKUN
Özden VURAL
Muzaffer DEMİR
BURHAN TURGUT
Aytemiz GÜRGEY
Hülya PARLAK
Nesrin DURAN
Pages
287–291
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

One thing is a keeping in mind to be the coexistence of FVL and the other known thrombophilic risk factors.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Activated protein C (APC) resistance has been found to be an important cause of venous thrombosis.
📊
Key Findings & Data:Total 467 healthy subjects were studied.
💡
Conclusion & Impact:One thing is a keeping in mind to be the coexistence of FVL and the other known thrombophilic risk factors.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Faktör V · Yaygınlık · Nüfus özellikleri

Özet

Activated protein C (APC) resistance has been found to be an important cause of venous thrombosis. The prevalence of F V Leiden (FVL) in general population is variable according to the region and the ethnic group. The aim of this study was to determine the prevalence of APC resistance and FVL in healthy population in Edirne as a representative sample of province of Edirne. Total 467 healthy subjects were studied. There were 238 males (50.96%) and 229 females (49.04%). APC resistance was studied by functional and DNA methods. There were a total 22/476 subjects (4.7%) were APC resistance. There were 20/476 subjects (4.28%) who had FVL by DNA test. Of these, there were 18 heterozygous and 2 homozygous FVL and other two subjects have no FVL mutation but have the high levels of FVIII to explain acquired APC resistance. The coexistence of FVL and the deficiencies of protein C (1/22), protein S (2/22) and antithrombin (1/22) were also studied. No one of subjects had prothrombin gene mutation. The data showed that the prevalence of APC resitance and FVL in healthy Turkish population were similar to the previously reported publications in Turkey and Europe. One thing is a keeping in mind to be the coexistence of FVL and the other known thrombophilic risk factors.

🔖

Cite This Article

VURKUN, M., VURAL, Ö., DEMİR, M., TURGUT, B., GÜRGEY, A., PARLAK, H., DURAN, N. (2002). The prevalence of activated protein C resistance and F V leiden in healthy population of Edirne, Turkey. Turkish Journal of Hematology, Cilt: 19 - Sayı: 2, 287–291. https://ajindex.com/articles/413006

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Egeberg O. Inherited antithrombin deficiency causing thrombophilia. Throm Diath Haemorrh 1965; 13:516
  2. Dahlback B. Inherited thrombophilia: Resistance to protein C as a pathogenetic factor of venous thromboembolism. Blood 1995;85:607-14
  3. De Stefano V, Finazzi G, Manucci PM. Inherited thrombophilia: Pathogenesis, clinical syndromes and management. Blood 1996;87:3531-44
  4. Akar N, Ulutin O, Cin Ç. Trombozda Moleküler Değişimler: Neonatal Hemostaz ve Tromboz. Ankara: 1999:41-57
  5. De Stefano S, Leone G, Mastrangelo S, Tripodi A, Rodeghiero F, Castaman G, Barbui T, Finazzi G, Biz- zi B, Manucci PM. Clinical manifestations and management of inherited thrombophilia: Retrospective analysis and follow-up after diagnosis of 238 patients with congenital deficiency of antithrombin III, protein C, protein S. Thromb Haemost 1994;72: 352-8
  6. Shafer AI. Hypercoagulabl. Genetics to clinical practice. Lancet 1994;334:1739-42
  7. Demir M, Vural Ö, Sunar H, Altun A, Yorulmaz F, Özbay G. The prevalence of hereditary thrombophilia in the Trakya region of Turkey. Yonsei Med J 2000;41:436-40
  8. Bertina RM, Koeleman BPC, Koester T, Rosendaal FR, Dirven RJ, de Ronde H, von der Velden PA, Reitsma PH. Mutation in blood coagulation factor associated with resistance to activated protein C. Nature 1994;369:64-7
  9. Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995;346:1133-4
  10. Özbek U, Tangün Y. Frequency of factor V Leiden (Arg 506 Gin) in Turkey (Letter). Br J Haematol 1997;97:504-5
  11. Dzimiri N, Meyer B. World distribution of factor V Leiden (Letter). Lancet 1996;347:481-2
  12. Awidi A, Shannak M, Bseiso A, Kaliani MA, Omar N, An Shasi B. Thromb Haemost 1999;81:582-4
  13. Takamiya O, Ishida F, Kodaira H, Kifano K. APC resistance and MnLI genotype (Gly 506) of coagulation factor V are rare in Japanise population (letter) Throm Haemost 1995;74:996
  14. Yavuz As, Karalar S, Tangün Y. Aktive protein C'ye direncin normal ve venöz trombozlu kişilerde araştı¬ rılması. XXIV. National Congress of Hematology; 1996 April 11-14, Istanbul-Turkey. Abstract Book, pp. 221
  15. Gürgey A, Mesci L, Renda Y, Olcay L, Koçak N, Er¬ dem G. Trombozlu çocuklarda FV Leiden mutasyonu. XXIV. National Congress of Hematology; 1996 Ap¬ ril 11-14, Istanbul-Turkey. Abstract Book. pp. 68
  16. Ganderille S, Greengard JS, Alhenc-Gelas M, Juhan- Vague I, Abgrall JF, Jude B, Griffin JH, Aiach M, and the French Network on behalf of INSERM. Incidence of activated protein C res